Friday, November 15, 2024
HomeTagsHoward Fillit

Howard Fillit

ADDF Statement on Gantenerumab Data Presented at CTAD

The phase 3 trial results for lecanemab and gantenerumab presented at the Clinical Trials on Alzheimer's Disease (CTAD) conference demonstrate why optimal treatment of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics